Skip to main content
PMC home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2006 Jun 3;9(3):217–233. doi: 10.1016/S1045-1870(98)80035-6

Viral pneumonia in children

Kelly J Henrickson 1,*
PMCID: PMC7129604  PMID: 32288452

Abstract

Viral pneumonia causes a heavy burden on our society. In the United States, more than one million cases of pneumonias afflict children under the age of 5 years, costing hundreds of millions of dollars annually. The majority of these infections are caused by a handful of common viruses. Knowledge of the epidemiology of these viruses combined with new rapid diagnostic techniques will provide faster and more, reliable diagnoses in the future. Although the basic clinical epidemiology of these viruses has been carefully investigated over the last 30 years, new molecular techniques are greatly expanding our understanding of these agents and the diseases they cause. Antigenic and genetic variations are being discovered in many viruses previously thought to be homogeneous. The exact roles and the biological significance of these variations are just beginning to be explored, but already evidence of differences in pathogenicity and immunogenicity has been found in many of these substrains. All of this information clearly will impact the development of future vaccines and antiviral drugs. Effective drugs exist for prophylaxis against influenza A and respiratory syncytial virus, and specific therapy exists for influenza A. Ribarivin is approved for use in respiratory synctial virus infections, and it alone or in combination with other agents (eg, IGIV) may be effective in immunocompromised patients, either in preventing the development of pneumonia or in decreasing morbidity and mortality. Many new antiviral agents are being tested and developed, and several are in clinical trials.

References

  • 1.Dowell SF, Anderson LJ, Gary HE. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J Infect Dis. 1996;174:456–462. doi: 10.1093/infdis/174.3.456. [DOI] [PubMed] [Google Scholar]
  • 2.Whimbey E, Englund JA, Ljungman P. Proceedings of a Symposium. Vol. 102. 1997. Community respiratory viral infections in the immunocompromised host; pp. 1–80. (Am J Med). [Google Scholar]
  • 3.Berman S. Epidemiology of acute respiratory infections in children of developing countries. Rev Infect Dis. 1991;13:S454–S462. doi: 10.1093/clinids/13.supplement_6.s454. [DOI] [PubMed] [Google Scholar]
  • 4.Monto AS. Acute respiratory infection in children of developing countries: Challenge of the 1990s. Rev Infect Dis. 1989;11:498–505. doi: 10.1093/clinids/11.3.498. [DOI] [PubMed] [Google Scholar]
  • 5.Kirkwood BR, Gove S, Rogers S. Potential interventions for the prevention of childhood pneumonia in developing countries: A systemic review. Bull World Health Org. 1995;73:793–798. [PMC free article] [PubMed] [Google Scholar]
  • 6.Hazlett DTG, Bell TM, Tukei PM. Viral etiology and epidemiology of acute respiratory infections in children in Nairobi, Kenya. Am J Trop Med Hyg. 1988;39:632–640. doi: 10.4269/ajtmh.1988.39.632. [DOI] [PubMed] [Google Scholar]
  • 7.Tuutu P, Halomen P, Meurman P. Viral lower respiratory tract infections in Fillipino children. J Infect Dis. 1990;161:175–279. doi: 10.1093/infdis/161.2.175. [DOI] [PubMed] [Google Scholar]
  • 8.Glezen WP, Loda FA, Clyde WAJ. Epidemiologic patterns of acute lower respiratory disease of children in a pediatric group practice. J Pediatr. 1971;78:397–406. doi: 10.1016/s0022-3476(71)80218-4. [DOI] [PubMed] [Google Scholar]
  • 9.Denny FW, Clyde WA., Jr Acute lower respiratory infections in nonhospitalized children. J Pediatr. 1986;108:635–646. doi: 10.1016/s0022-3476(86)81034-4. [DOI] [PubMed] [Google Scholar]
  • 10.Wright AL, Taussig LM, Ray G. The Tucson children's respiratory study. II. Lower respiratory tract illness in the first year of life. Am J Epidemiol. 1989;129:1232–1246. doi: 10.1093/oxfordjournals.aje.a115243. [DOI] [PubMed] [Google Scholar]
  • 11.Jennings LC, Dawson KP, Abbott GD. Acute respiratory tract infections of children in hospital: A viral and mycoplasma pneumoniae profile. N Z Med J. 1985;98:582–585. [PubMed] [Google Scholar]
  • 12.Murphy B, Phelan PD, Jack I. Seasonal pattern in childhood viral lower respiratory tract infections in Mclbourne. Med J Aust. 1980;1:22–24. doi: 10.5694/j.1326-5377.1980.tb134568.x. [DOI] [PubMed] [Google Scholar]
  • 13.Kellner G, Popow-Kraupp T, Kundi M. Contribution of rhinoviruses to respiratory viral infections in childhood. A prospective study in a mainly hospitalized infant population. J Med Virol. 1988;25:455–469. doi: 10.1002/jmv.1890250409. [DOI] [PubMed] [Google Scholar]
  • 14.Belshe RB, Van Voris LP, Mufson MA. Impact of viral respiratory diseases on infants and young children in a rural and urban area of southern West Virginia. Am J Epidemiol. 1983;117:467–474. doi: 10.1093/oxfordjournals.aje.a113564. [DOI] [PubMed] [Google Scholar]
  • 15.Murphy TF, Henderson FW, Clyde WA. Pneumonia: An eleven-year study in a pediatric practice. Am J Epidemiol. 1981;113:12–21. doi: 10.1093/oxfordjournals.aje.a113061. [DOI] [PubMed] [Google Scholar]
  • 16.Henrickson KJ, Kuhn SM, Savatski LL. Epidemiology and cost of human parainfluenza virus type one and two infections in young children. Clin Infect Dis. 1994;18:770–779. doi: 10.1093/clinids/18.5.770. [DOI] [PubMed] [Google Scholar]
  • 17.Foy HM, Cooney MK, Maletzky AJ. Incidence and etiology of pneumonia, croup and bronchiolitis in preschool children belonging to a prepaid medical care group over a four-year period. Am J Epidemiol. 1973;97:80–92. doi: 10.1093/oxfordjournals.aje.a121492. [DOI] [PubMed] [Google Scholar]
  • 18.Yun BY, Kim MR, Park JY. Viral etiology and epidemiology of acute lower respiratory tract infections in Korean children. Pediatr Infect Dis J. 1995;14:1054–1059. doi: 10.1097/00006454-199512000-00005. [DOI] [PubMed] [Google Scholar]
  • 19.Downham MAPS, McQuillin J, Gardner PS. Diagnosis and clinical significance of parainfluenza virus infections in children. Arch Dis Child. 1974;49:8–15. doi: 10.1136/adc.49.1.8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Heilman CA. From the National Institute, of Allergy and Infectious Diseases and the Worlds Health Organization. Respiratory syncytial and parainfluenza viruses. J Infect Dis. 1990;161:402–406. doi: 10.1093/infdis/161.3.402. [DOI] [PubMed] [Google Scholar]
  • 21.Singhi S, Dhawan A, Kataria S. Clinical signs of pneumonia in infants under two months. Arch Dis Child. 1994;70:413–417. doi: 10.1136/adc.70.5.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Nohynek H, Eskola J, Laine E. The causes of hospital-treated acute lower respiratory tract infection in children. Am J Dis Child. 1991;145:618–622. doi: 10.1001/archpedi.1991.02160060036016. [DOI] [PubMed] [Google Scholar]
  • 23.Hortal M, Suarez A, Deleon C. Etiology and severity of community acquired pneumonia in children from Uruguay: A 4 year study. Rev Inst Med Trop Sao Paulo. 1994;36:255–264. doi: 10.1590/s0036-46651994000300010. [DOI] [PubMed] [Google Scholar]
  • 24.Davies HD, Wang EEL, Manson D. Reliability of the chest radiograph in the diagnosis of lower respiratory infections in young children. Pediatr Infect Dis J. 1996;15:600–604. doi: 10.1097/00006454-199607000-00008. [DOI] [PubMed] [Google Scholar]
  • 25.Greenberg SB. Viral pneumonia. Infect Dis Clin N Am. 1991;5:603–621. [PubMed] [Google Scholar]
  • 26.Falsey AR, Cunningham CK, Barker WH. Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J Infect Dis. 1995;172:389–394. doi: 10.1093/infdis/172.2.389. [DOI] [PubMed] [Google Scholar]
  • 27.Drews AL, Atmar BL, Glezen WP. Dual respiratory virus infections. Clin Infect Dis. 1997;25:1421–1429. doi: 10.1086/516137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Glezen WP, Frank AL, Taber LH. Parainfluenza virus type 3: Seasonality and risk of infection and reinfection in young. J Infect Dis. 1984;150:851–857. doi: 10.1093/infdis/150.6.851. [DOI] [PubMed] [Google Scholar]
  • 29.Glezen WP, Taber LH, Frank AL. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child. 1986;140:543–546. doi: 10.1001/archpedi.1986.02140200053026. [DOI] [PubMed] [Google Scholar]
  • 30.Abzug MJ, Beam AC, Gyorkos WA. Viral pneumonia in the first month of life. Pediatr Infect Dis J. 1990;9:881–885. doi: 10.1097/00006454-199012000-00005. [DOI] [PubMed] [Google Scholar]
  • 31.Glezen WP, Atmar RL, Falcao O. Respiratory virus infections in patients hospitalized with acute respiratory conditions. Program and Abstract of the 34th Infectious Diseases Society of America Annual Meeting; Orlando, FL; October 4–7, 1994. (abstr 102) [Google Scholar]
  • 32.Glezen WP, Loda FA, Clyde WAJ. Epidemiologic patterns of acute lower respiratory disease in children in a pediatric group practice. J Pediatr. 1971;78:397–406. doi: 10.1016/s0022-3476(71)80218-4. [DOI] [PubMed] [Google Scholar]
  • 33.Siegel FP, Dikman SH, Arayata RB. Fatal disseminated adenovirus 11 pneumonia in agammaglobulinemic patient. Am J Med. 1981;71:1062–1067. doi: 10.1016/0002-9343(81)90343-0. [DOI] [PubMed] [Google Scholar]
  • 34.Wigger HJ, Blanc WA. Fatal hepatic and bronchial necrosis in adenovirus infection with thymic alymphoplasia. N Engl J Med. 1966;275:870–874. doi: 10.1056/NEJM196610202751603. [DOI] [PubMed] [Google Scholar]
  • 35.Karp D, Willis J, Wilfert CM. Parainfluenza virus II and the immunocompromised host. Am J Dis Child. 1974;127:592–593. doi: 10.1001/archpedi.1974.02110230138025. [DOI] [PubMed] [Google Scholar]
  • 36.Delange G, Brochu P, Pelletier M. Giant-cell pneumonia caused by parainfluenza virus. J Pediatr. 1979;94:426–429. doi: 10.1016/s0022-3476(79)80591-0. [DOI] [PubMed] [Google Scholar]
  • 37.McIntosh K, Kurachek SC, Cairns LM. Treatment of respiratory viral infection in an immunodeficient infant with ribavirin aerosol. Am J Dis Child. 1984;138:305–308. doi: 10.1001/archpedi.1984.02140410083024. [DOI] [PubMed] [Google Scholar]
  • 38.Weintrub PS, Sullender WM, Lombard C. Giant cell pneumonia caused by parainfluenza type 3 in a patient with acute myelomonocytic leukemia. Arch Pathol Lab Med. 1987;111:569–570. [PubMed] [Google Scholar]
  • 39.Wendt CH, Weisdorf DJ, Jordan MC. Parainfluenza virus respiratory infection after bone marrow transplantation. N Engl J Med. 1992;326:921–926. doi: 10.1056/NEJM199204023261404. [DOI] [PubMed] [Google Scholar]
  • 40.Beard LJ, Robertson EF, Thong YH. Para-influenza pneumonia in DiGeorge syndrome two years after thymic epithelial transplantation. Acta Pacdiatr Scand. 1980;69:403–406. doi: 10.1111/j.1651-2227.1980.tb07100.x. [DOI] [PubMed] [Google Scholar]
  • 41.King JC, Burke AR, Clemens JD. Respiratory syncytial virus illnesses in human immunodeficiency virus and noninfected children. Pediatr Infect Dis J. 1993;12:733–739. doi: 10.1097/00006454-199309000-00006. [DOI] [PubMed] [Google Scholar]
  • 42.Josephs S, Kim HW, Brandt CD. Parainfluenza 3 virus and other common respiratory pathogens, in children with human immunodeficiency virus infection. Pediatr Infect Dis J. 1988;7:207–209. [PubMed] [Google Scholar]
  • 43.McSherry GD. Human immunodeficiency-virus-related pulmonary infections in children. Sem Respir Infect. 1996;11:173–183. [PubMed] [Google Scholar]
  • 44.Mauch TJ, Bratton S, Myers T. Influenza B virus infection in pediatric solid organ transplant recipients. Pediatrics. 1994;94:225–229. [PubMed] [Google Scholar]
  • 45.Apalsch AM, Green M, Wald ER. Influenza and parainfluenza virus infections in pediatric organ transplant recipients. Program and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy; Anaheim, CA; October 11–14, 1992. [Google Scholar]
  • 46.Arola M, Ruuskanen O, Ziegler T. Respiratory virus infections during anticancer treatment in children. Pediatr Infect Dis J. 1995;14:660–694. doi: 10.1097/00006454-199508000-00008. [DOI] [PubMed] [Google Scholar]
  • 47.Flomenberg P, Babbitt J, Drobyski WR. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis. 1994;169:775–781. doi: 10.1093/infdis/169.4.775. [DOI] [PubMed] [Google Scholar]
  • 48.Fields BN, Knipe DM, Howley PM. Raven; New York, NY: 1996. Virology. [Google Scholar]
  • 49.Henrickson KJ. Parainfluenza viruses. In: Lennette EH, editor. Diagnostic procedures for viral, rickettsial and chlamydia infections. American Public Health Association; Washington, DC: 1995. pp. 481–494. [Google Scholar]
  • 50.Hall CB. Parainfluenza viruses. In: Feigin RD, Cherry JD, editors. Texbook of Pediatric Infectious Diseases. ed 4. Saunders; Philadelphia, PA: 1992. p. 1613. [Google Scholar]
  • 51.Glezen WP, Taber LH, Frank AL. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child. 1986;140:543–546. doi: 10.1001/archpedi.1986.02140200053026. [DOI] [PubMed] [Google Scholar]
  • 52.Anderson LJ, Hendry RM, Pierik LT. Multicenter study of strains of respiratory syncytial virus. J Infect Dis. 1991;163:687–692. doi: 10.1093/infdis/163.4.687. [DOI] [PubMed] [Google Scholar]
  • 53.McConnochie KM, Hall CB, Walshe EE. Variation and severity of respiratory syncytial virus infection with subtype. J Pediatr. 1990;117:52–62. doi: 10.1016/s0022-3476(05)82443-6. [DOI] [PubMed] [Google Scholar]
  • 54.Walsh EE, McConnochie KM, Long CE. Severity of respiratory syncytial virus infection is related to virus strain. J Infect Dis. 1997;175:814–820. doi: 10.1086/513976. [DOI] [PubMed] [Google Scholar]
  • 55.Stark JM, Fatermi SH, Amini SB. Occurrence of respiratory syncytial virus subtypes in hospitalized children in Cleveland, Ohio from 1985 to 1988. Pediatr Pulmonol. 1991;11:98–102. doi: 10.1002/ppul.1950110204. [DOI] [PubMed] [Google Scholar]
  • 56.Canchola J, Vargosko AJ, Kim AW. Antigenic variation among newly isolated strains of parainfluenza type 4 virus. Am J Hyg. 1964;79:357–364. doi: 10.1093/oxfordjournals.aje.a120390. [DOI] [PubMed] [Google Scholar]
  • 57.Henrickson KJ. Monoclonal antibodies to human parainfluenza virus type 1 detect major antigenic changes in clinical isolates. J Infect Dis. 1991;164:1128–1134. doi: 10.1093/infdis/164.6.1128. [DOI] [PubMed] [Google Scholar]
  • 58.Henrickson KJ, Savatski L. Genetic variation and evolution of human parainfluenza virus type 1: Analysis of 12 clinical isolates. J Infect Dis. 1992;166:995–1005. doi: 10.1093/infdis/166.5.995. [DOI] [PubMed] [Google Scholar]
  • 59.Henrickson KJ, Savatski L. Two distinct human parainfluenza virus type one genotypes detected during the 1991 epidemic. J Clin Microbiol. 1996;34:695–700. doi: 10.1128/jcm.34.3.695-700.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Henrickson KJ, Savatski LL. Antigenic structure, function and evolution of the hemagglutinin neuraminidase protein of human parainfluenza virus type 1. J Infect Dis. 1997;176:867–875. doi: 10.1086/516533. [DOI] [PubMed] [Google Scholar]
  • 61.Skolnik NS. Treatment of croup. A critical review. Am J Dis Child. 1989;143:1045–1049. doi: 10.1001/archpedi.1989.02150210079022. [DOI] [PubMed] [Google Scholar]
  • 62.Wright PF. Parainfluenza viruses. In: Belshe RB, editor. Textbook of Human Virology. Mosby-Year Book; St Louis, MO: 1991. pp. 342–350. [Google Scholar]
  • 63.de Silva LM, Cloonan MJ. Brief report: parainfluenza virus type 3 infections: Findings in Sydney and some observations on variations in seasonality world-wide. J Med Virol. 1991;35:19–21. doi: 10.1002/jmv.1890350105. [DOI] [PubMed] [Google Scholar]
  • 64.Killgore GE, Dowdle WR. Antigenic characterization of parainfluenza 4A and 4B by the hemagglutination-inhibition test and distribution of HI antibody in human sera. Am J Epidemiol. 1970;91:308–316. doi: 10.1093/oxfordjournals.aje.a121141. [DOI] [PubMed] [Google Scholar]
  • 65.Chanock RM, Parrott R. Acute respiratory disease in infancy and childhood: Present understanding and prospects for prevention. E. Mead Johnson Address, October, 1964. Pediatrics. 1965;36:21–39. [PubMed] [Google Scholar]
  • 66.Gardner SD. The isolation of parainfluenza 4 subtypes A and B in England and serological studies of their prevalence. J Hyg (Camb) 1969;67:545–550. doi: 10.1017/s002217240004198x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Canchola JG, Chanock RM, Jeffries BC. Recovery and identification of human myxoviruses. Bacteriol Rev. 1965;29:496–503. doi: 10.1128/br.29.4.496-503.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Lindquist SW, Darnule A, Istas A. Parainfluenza virus type 4 infections in pediatric patients. Pediatr Infect Dis J. 1997;16:35–38. doi: 10.1097/00006454-199701000-00008. [DOI] [PubMed] [Google Scholar]
  • 69.Centers for Disease Control and Prevention CDC Surveillance Summaries, September 4, 1992. MMWR. 1992;41:35–43. [Google Scholar]
  • 70.Glezen WP. Management and prevention of influenza and prospects for the future. Rep Pediatr Infect Dis. 1992;2:37–39. [Google Scholar]
  • 71.Hierbolzer JC. Adenoviruses in the immunocompromised host. Clin Microbiol Rev. 1992;5:262–274. doi: 10.1128/cmr.5.3.262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Cherry JD. Adenoviral Infections. In: Feigin RD, Cherry JD, editors. Textbook of Pediatric Infections Diseases. 1992. pp. 1670–1687. Philadelphia, PA. [Google Scholar]
  • 73.Horowitz MS. Adenoviruses. In: Fields BN, editor. Virology. Lippincott; Philadelphia, PA: 1996. pp. 2149–2171. [Google Scholar]
  • 74.Kajon AE, Wadell G. Molecular epidemiology of adenoviruses associated with acute lower respiratory disease of children in Buenos Aires, Argentina (1984–1988) J Med Virol. 1992;36:292–297. doi: 10.1002/jmv.1890360411. [DOI] [PubMed] [Google Scholar]
  • 75.Brandt CD, Kim HW, Jeffries BG. Infections in 18,000 infants and children in a controlled study of respiratory tract disease. II. Variation in adenovirus infections by year and season. Am J Epidemiol. 1972;95:218–227. doi: 10.1093/oxfordjournals.aje.a121389. [DOI] [PubMed] [Google Scholar]
  • 76.Nelson KE, Gavitt F, Batt MD. The role of adenoviruses in the pertussis syndrome. J Pediatr. 1975;86:335–341. doi: 10.1016/s0022-3476(75)80959-0. [DOI] [PubMed] [Google Scholar]
  • 77.Maletzky AJ, Cooney MK, Luce R. Epidemiology of viral and mycoplasmal agents associated with childhood lower respiratory illness in a civilian population. J Pediatr. 1971;78:407–414. doi: 10.1016/s0022-3476(71)80219-6. [DOI] [PubMed] [Google Scholar]
  • 78.Edwards KM, Thompson J, Paolina J. Adenovirus infections in young children. Pediatrics. 1985;76:420–424. [PubMed] [Google Scholar]
  • 79.Dick EC, Inhorn SL. Rhinoviruses. In: Feigin RD, Cherry JD, editors. Textbook of Pediatric Infectious Disease. Saunders Co; Philadelphia, PA: 1992. pp. 1507–1531. [Google Scholar]
  • 80.Monto AS. The Tecumseh study of respiratory illenss. V. Patterns of infection with parainfluenza viruses. Am J Epidemiol. 1971;97:338–348. doi: 10.1093/oxfordjournals.aje.a121514. [DOI] [PubMed] [Google Scholar]
  • 81.Kellner G, Popow-Kraupp T, Binder C. Respiratory tract infections due to different rhinovirus scrotypes and the influence of maternal antibodies on the clinical expression of the disease in infants. J Med Virol. 1991;35:267–272. doi: 10.1002/jmv.1890350412. [DOI] [PubMed] [Google Scholar]
  • 82.Schmidt HJ, Fink RJ. Rhinovirus as a lower respiratory tract pathogen in infants. Pediatr Infect Dis J. 1991;10:700–702. doi: 10.1097/00006454-199109000-00015. [DOI] [PubMed] [Google Scholar]
  • 83.Isaacs D, Flowers DR, Clarke JR. Epidemiology of coronavirus respiratory infections. Arch Dis Child. 1983;58:500–503. doi: 10.1136/adc.58.7.500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Larson HE, Reed SE, Tyrell DAJ. Isolation of rhinoviruses and coronaviruses from 33 colds in adults. J Med Virol. 1980;5:221–229. doi: 10.1002/jmv.1890050306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Mertsola J, Ziegler T, Ruuskanen O. Recurrent wheezy bronchitis and viral respiratory infections. Arch Dis Child. 1991;66:124–129. doi: 10.1136/adc.66.1.124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.McIntosh K, McQuillin J, Reed SE. Diagnosis of human coronavirus infection by immunofluorescence: Method and application to respiratory disease in hospitalized children. J Med Virol. 1978;2:341–346. doi: 10.1002/jmv.1890020407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.McLean DM, Bannatyne MB, Givan KF. Myxovirus dissemination by air. Can Med Assoc J. 1967;96:1449–1453. [PMC free article] [PubMed] [Google Scholar]
  • 88.Hall CB, Douglas RG, Geiman JM. Nosocomial respiratory syncytial virus infections. N Engl J Med. 1975;293:1343–1346. doi: 10.1056/NEJM197512252932604. [DOI] [PubMed] [Google Scholar]
  • 89.Hall CB, Douglas RG. Modes of transmission of respiratory syncytial virus. J Pediatr. 1981;99:100–103. doi: 10.1016/s0022-3476(81)80969-9. [DOI] [PubMed] [Google Scholar]
  • 90.Brady MT, Evans J, Cuartas J. Survival and disinfection of parainfluenza viruses on environmental surfaces. Am J Infect Control. 1990;18:18–23. doi: 10.1016/0196-6553(90)90206-8. [DOI] [PubMed] [Google Scholar]
  • 91.Ansari SA, Springthorpe VS, Sattar SA. Potential role of hands in the spread of respiratory viral infections: Studies with human parainfluenza virus 3 and rhinovirus 14. J Clin Microbiol. 1991;29:2115–2119. doi: 10.1128/jcm.29.10.2115-2119.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Alford RH, Kasel JA, Gerone PJ. Vol. 122. 1966. Human influenza resulting from aerosol inhalation; pp. 800–804. (Proc Soc Exp Biol Med). [DOI] [PubMed] [Google Scholar]
  • 93.Couch RB, Cate TR, Fleet WF. Aerosol-induced adenoviral illness resembling the naturally occurring illness in military recruits. Am Rev Respir Dis. 1965;93:529–535. doi: 10.1164/arrd.1966.93.4.529. [DOI] [PubMed] [Google Scholar]
  • 94.Dick EC, Jennings LC, Mink KA. Aerosol transmission of rhinovirus colds. J Infect Dis. 1987;156:442–448. doi: 10.1093/infdis/156.3.442. [DOI] [PubMed] [Google Scholar]
  • 95.Turner RB, Lande AE, Chase P. Pneumonia in pediatric outpatients: Cause and clinical manifestations. J Pediatr. 1987;111:194–200. doi: 10.1016/S0022-3476(87)80066-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Harris DJ, Wulff H, Ray GG. Viruses and disease> III. An outbreak of adenovirus type 7A in a children's home. Am J Epidemiol. 1971;93:399–402. doi: 10.1093/oxfordjournals.aje.a121273. [DOI] [PubMed] [Google Scholar]
  • 97.Glezen WP, Couch RB, Taber LH. Original contributions epidemiologic observations of influenza B virus infections in Houston, Texas, 1976–1977. Am J Epidemiol. 1980;111:13–22. doi: 10.1093/oxfordjournals.aje.a112865. [DOI] [PubMed] [Google Scholar]
  • 98.Cavallaro JJ, Monto AS. Community-wide outbreak of infection with a 229E-like coronavirus in Tecumseh, Michigan. J Infect Dis. 1970;122:272–279. doi: 10.1093/infdis/122.4.272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Hendley JO, Gwaltney JM. Mechanisms of transmission of rhinovirus infections. Epidemiol Rev. 1988;10:242–258. [PubMed] [Google Scholar]
  • 100.Mufson MA, Mocega HE, Krause HE. Acquisition of parainfluenza 3 virus infection by hospitalized children. I. Frequencies, rates and temporal data. J Infect Dis. 1973;128:141–147. doi: 10.1093/infdis/128.2.141. [DOI] [PubMed] [Google Scholar]
  • 101.Gardner PS. How etiologic, pathologic, and clinical diagnosis can be made in a correlated fashion. Pediatr Res. 1977;11:254–261. [PubMed] [Google Scholar]
  • 102.Hall CB, Douglas RG. Nosocomial influenza infection as a cause of intercurrent fevers in infants. Pediatrics. 1975;55:673–677. [PubMed] [Google Scholar]
  • 103.Finn A, Anday E, Talbot GH. An epidemic of adenovirus 7a infection in a neonatal nursery: Course, morbidity, and management. Infect Control Hosp Epidemiol. 1988;9:398–404. doi: 10.1086/645898. [DOI] [PubMed] [Google Scholar]
  • 104.Meibalane R, Sedmak GV, Sasidharam P. Outbreak of influenza in a neonatal intensive care unit. J Pediatr. 1977;91:974–976. doi: 10.1016/s0022-3476(77)80907-4. [DOI] [PubMed] [Google Scholar]
  • 105.Kirkwood BR, Gove S, Rogers S. Potential interventions for the prevention of childhood pneumonia in developing countries: A systematic review. Bull World Health Organ. 1995;73:793–798. [PMC free article] [PubMed] [Google Scholar]
  • 106.Andiman WA, Jacobson RI, Tucker G. Leukocyte-associated viremia with adenovirus type 2 in an infant with lower-respiratory tract disease. N Engl J Med. 1977;297:100–101. doi: 10.1056/NEJM197707142970208. [DOI] [PubMed] [Google Scholar]
  • 107.Yanagihara R, McIntosh K. Secretory immunological response in infants and children to parainfluenza virus types 1 and 2. Infect Immun. 1980;30:23–28. doi: 10.1128/iai.30.1.23-28.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Douglas RG, Couch RB. Vol. 139. 1972. Parenteral inactivated rhinovirus vaccine: Minimal protective effect; pp. 899–902. (Proc Soc Exp Med). [DOI] [PubMed] [Google Scholar]
  • 109.Downie JC, Stuart-Harris CH. The production of neutralizing activity in serum and nasal secretion following immunization with influenza B virus. J Hyg (Camb) 1970;68:233–244. doi: 10.1017/s0022172400028709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Hall CB, Walsh EE, Long CE. Immunity to and frequency of reinfection with respiratory syncyial virus. J Infect Dis. 1991;163:693–698. doi: 10.1093/infdis/163.4.693. [DOI] [PubMed] [Google Scholar]
  • 111.Murphy BR, Graham BS, Prince GA. Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. J Clin Microbiol. 1986;23:1009–1014. doi: 10.1128/jcm.23.6.1009-1014.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112.Glezen WP, Taber LH, Frank AL. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child. 1986;140:543–546. doi: 10.1001/archpedi.1986.02140200053026. [DOI] [PubMed] [Google Scholar]
  • 113.Johnson PR, Olmsted RA, Prince GA. Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: Evaluation of the contributions of F and G glycoproteins to immunity. J Virol. 1987;10:3163–3166. doi: 10.1128/jvi.61.10.3163-3166.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Henderson FW. Pulmonary cell-mediated cytotoxicity in hamsters with parainfluenza virus type 3 pneumonia. Am Rev Respir Dis. 1979;120:41–47. doi: 10.1164/arrd.1979.120.1.41. [DOI] [PubMed] [Google Scholar]
  • 115.Kimmel KA, Wyde PR, Glezen WP. Evidence of a T-cell-mediated cytotoxic response to parainfluenza virus type 3 pneumonia in hamsters. J Reticuloendothel Soc. 1982;31:71–83. [PubMed] [Google Scholar]
  • 116.Munoz JL, McCarthy CA, Clark ME. Respiratory syncytial virus infection in C57BL/6 mice: Clearance of virus from the lungs with virus specific T cells. J Virol. 1991;65:4494–4497. doi: 10.1128/jvi.65.8.4494-4497.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117.Kast WM, Bluestone JA, Heemskerk MH. Treatment with monoclonal anti-CD3 antibody protects against lethal Sendai virus infection by induction of natural killer cells. J Immunol. 1990;145:2254–2259. [PubMed] [Google Scholar]
  • 118.Doherty PC, Allan W, Eichelberger M. Involvement of gamma delta T cells in respiratory virus infection. Curr Top Microbiol Immunol. 1991;173:291–296. [PubMed] [Google Scholar]
  • 119.Vasantha S, Coelingh KL, Murphy BR. Interactions of a nonneutralizing IgM antibody and complement in parainfluenza virus neutralization. Virology. 1988;167:433–441. [PubMed] [Google Scholar]
  • 120.Mochizuki Y, deMing T, Hayashi T. Protection of mice against sendai virus pneumonia by non-neutralizing anti-F monoclonal antibodies. Microbiol Immunol. 1990;34:171–183. doi: 10.1111/j.1348-0421.1990.tb01002.x. [DOI] [PubMed] [Google Scholar]
  • 121.Falsey AR. Noninfluenza respiratory infection in long-term care facilities. Infect Control Hosp Epidemiol. 1991;12:602–608. doi: 10.1086/646249. [DOI] [PubMed] [Google Scholar]
  • 122.Reed SE. The behavior of recent isolates of human respiratory coronavirus in vitro and in volunteers: Evidence of heterogeneity among 229E-related strains. J Med Virol. 1984;13:179–192. doi: 10.1002/jmv.1890130208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 123.Bell JA, Ward TG, Hubner RJ. Studies of adenoviruses (APC) in volunteers. Am J Pub Health. 1956;46:1130–1146. doi: 10.2105/ajph.46.9.1130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.McIntosh K, Kuracheck SC, Cairns LM. Treatment of respiratory viral infection in an immunodeficient infant with ribavirin aerosol. Am J Dis Child. 1984;138:305–308. doi: 10.1001/archpedi.1984.02140410083024. [DOI] [PubMed] [Google Scholar]
  • 125.Weintrub PS, Sullender WM, Lombard C. Giant cell pneumonia caused by parainfluenza type 3 in a patient with acute myelomonocytic leukemia. Arch Pathol Lab Med. 1987;111:569–570. [PubMed] [Google Scholar]
  • 126.DeFabritus AM, Riggio RR, David DS. Parainfluenza type 3 in a transplant unit. JAMA. 1979;241:384–386. [PubMed] [Google Scholar]
  • 127.Green M, Wold WS, Mackey J. Vol. 76. 1979. Analysis of human tonsil and cancer DNAs and RNAs for DN sequences of group C (serotypes 1, 2, 5, and 6) human adenoviruses; pp. 6606–6610. (Proc Natl Acad Sci USA). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128.Horvath J, Palkonyay L, Weber J. Group C adenovirus DNA sequences in human lymphoid cells. J Virol. 1986;59:189–192. doi: 10.1128/jvi.59.1.189-192.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129.Hogg JC. Latent viral infections in airway epithelium. Chest. 1992;101:80S–82S. doi: 10.1378/chest.101.3_supplement.80s. [DOI] [PubMed] [Google Scholar]
  • 130.Isaacs D. Problems in determining the etiology of community-acquired childhood pneumonia. Pediatr Infect Dis J. 1989;8:143–148. [PubMed] [Google Scholar]
  • 131.Redd SC, Patrick E, Vreuls R. Comparison of the clinical and radiographic diagnosis of paediatric pneumonia. Trans R Soc Trop Med Hyg. 1994;88:307–310. doi: 10.1016/0035-9203(94)90092-2. [DOI] [PubMed] [Google Scholar]
  • 132.Kiekara O, Korppi M, Tanska S. Radiological diagnosis of pneumonia in children. Ann Med. 1996;28:69–72. doi: 10.3109/07853899608999077. [DOI] [PubMed] [Google Scholar]
  • 133.Babcook CJ, Norman GR, Coblentz CL. Effect of clinical history on the interpretation of chest radiographs in childhood bronchiolitis. Invest Radiol. 1993;28:214–217. doi: 10.1097/00004424-199303000-00005. [DOI] [PubMed] [Google Scholar]
  • 134.Puthavathana P, Wasi C, Kositanont U. A hospital-based study of acute viral infections of the respiratory tract in Thai children, with emphasis on laboratory diagnosis. Rev Infect Dis. 1990;12:S988–S994. doi: 10.1093/clinids/12.supplement_8.s988. [DOI] [PubMed] [Google Scholar]
  • 135.Woo PCY, Chiu SS, Seto WH. Cost-effectiveness of rapid diagnosis of viral respiratory tract infections in pediatric patients. J Clin Microbiol. 1997;35:1579–1581. doi: 10.1128/jcm.35.6.1579-1581.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 136.Hall CB, Geiman JM, Breese BB. Parainfluenza viral infections in children: Correlation of shedding with clinical manifestations. J Pediatr. 1977;91:194–198. doi: 10.1016/s0022-3476(77)80811-1. [DOI] [PubMed] [Google Scholar]
  • 137.Wong DT, Welliver RC, Riddlesberger KR. Rapid diagnosis of parainfluenza virus infection in children. J Clin Microbiol. 1982;16:164–167. doi: 10.1128/jcm.16.1.164-167.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 138.Hendley JO, Gwaltney JMJ, Jordan SWJ. Rhinovirus infections in an industrial population. IV. Infections within families of employees during two fall peaks of respiratory illness. Am J Epidemiol. 1969;89:184–196. doi: 10.1093/oxfordjournals.aje.a120928. [DOI] [PubMed] [Google Scholar]
  • 139.Barnes SD, Leclair JM, Forman MS. Comparison of nasal brush and nasopharyngeal aspirate techniques in obtaining specimens for detection of respiratory syncytial viral antigen by immunoflourescece. Pediatr Infect Dis J. 1989;8:598–601. doi: 10.1097/00006454-198909000-00006. [DOI] [PubMed] [Google Scholar]
  • 140.Ahluwalia G, Embree J, McNicol P. Comparison of nasopharyngeal aspirate and nasopharyngeal swab specimens for respiratory syncytinal virus diagnosis by cell culture, indirect immunoflourescence assay, and enzyme-linked immunosorbent assay. J Clin Microbiol. 1987;25:763–767. doi: 10.1128/jcm.25.5.763-767.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 141.Wooden KA, Hall CB, Leibenguth KC. American Society of Microbiology; Los Angeles, CA: October, 1988. Variables affecting the rapid diagnosis of respiratory syncytial virus (RSV) p. 145. (Abstract of the 1984 ICAAC). No. 204. [Google Scholar]
  • 142.Jalowayski AA, Walpita P, Puryear BA. Rapid detection of respiratory syncytial virus in nasopharyngeal specimens obtained with the rhinoprobe scraper. J Clin Microbiol. 1990;28:738–741. doi: 10.1128/jcm.28.4.738-741.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 143.Henrickson KJ, Kuhn SM, Savatski LL. Recovery of human parainfluenza virus types one and two. J Virol Methods. 1994;46:189–206. doi: 10.1016/0166-0934(94)90103-1. [DOI] [PubMed] [Google Scholar]
  • 144.Waner JL, Whitehurst NJ, Todd SJ. Comparison of directigen RSV with viral isolation and direct immunofluorescence for the identification of respiratory syncytial virus. J Clin Microbiol. 1990;28:480–483. doi: 10.1128/jcm.28.3.480-483.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 145.Salomon HE, Grandien M, Avila MM. Comparison of three techniques for detection of respiratory viruses in nasopharyngeal aspirates from children with lower acute respiratory infection. J Med Virol. 1989;28:159–162. doi: 10.1002/jmv.1890280310. [DOI] [PubMed] [Google Scholar]
  • 146.Sarkkinen HK, Halonen PE, Salmi AA. Type-specific detection of parainfluenza viruses by enzyme-immunoassay and radioimmunoassay in nasopharyngeal specimens of patients with acute respiratory disease. J Gen Virol. 1981;56:49–57. doi: 10.1099/0022-1317-56-1-49. [DOI] [PubMed] [Google Scholar]
  • 147.Hierholzer JC, Bingham PG, Coombs RA. Comparison of monoclonal antibody time-resolved fluoroimmunoassay with monoclonal antibody capture-biotinylated detector enzyme immunoassay for respiratory syncytial virus and parainfluenza virus antigen detection. J Clin Microbiol. 1989;27:1243–1249. doi: 10.1128/jcm.27.6.1243-1249.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 148.Thiele GM, Okano M, Purtilo DT. Enzyme-linked immunosorbent. Virol Methods. 1989;23:321–332. doi: 10.1016/0166-0934(89)90164-x. ay (ELISA) for detecting antibodies in sera of patients with adenovirus infection. [DOI] [PubMed] [Google Scholar]
  • 149.Johnston SL, Bloy H. Evaluation of a rapid enzyme immunoassay for detection of influenza A virus. J Clin Microbiol. 1993;31:142–143. doi: 10.1128/jcm.31.1.142-143.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 150.Centers for Disease Control National Respiratory and Enteric Virus Surveillance system Monthly Report. 1992;2:1–11. [Google Scholar]
  • 151.Wong DT, Welliver RC, Riddlesberger KR. Rapid diagnosis of parainfluenza virus infection in children. J Clin Microbiol. 1992;16:164–167. doi: 10.1128/jcm.16.1.164-167.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 152.Treuhaft MW, Soukup JM, Sullivan BJ. Practical recommendations for the detection of pediatric respiratory syncytial virus infections. J Clin Microbiol. 1985;22:270–273. doi: 10.1128/jcm.22.2.270-273.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 153.Swierkosz EM, Flanders R, Melvin L. Evaluation of the Abbott TESTPACK RSV enzyme immunoassay for detection of respiratory syncytial virus in nasopharyngeal swab specimens. J Clin Microbiol. 1989;27:1151–1154. doi: 10.1128/jcm.27.6.1151-1154.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 154.Stout C, Murphy MD, Lawrence S. Evaluation of monoclonal antibody pool for rapid diagnosis of respiratory viral infections. J Clin Microbiol. 1989;27:448–452. doi: 10.1128/jcm.27.3.448-452.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 155.Ray CG, Minnich LL. Efficiency of immunofluorescence for rapid detection of common respiratory viruses. J Clin Microbiol. 1987;25:335–357. doi: 10.1128/jcm.25.2.355-357.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 156.Blanding JG, Hoshiko MG, Stutman HR. Routine viral culture for pediatric respiratory specimens submitted for direct immunofluorescence testing. J Clin Microbiol. 1989;27:1438–1440. doi: 10.1128/jcm.27.7.1438-1440.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 157.Leland DS. Direct detection for viral diagnosis. 13th Annual Clinical Virology Symposium; Clearwater Beach, FL; April 27–30, 1997. pp. 13–15. (abstr) [Google Scholar]
  • 158.Hornsleth A. A rapid test for detection of respiratory syncytial virus in nasopharyngeal secretion. Eur J Clin Microbiol Infect Dis. 1990;9:356–358. doi: 10.1007/BF01973745. [DOI] [PubMed] [Google Scholar]
  • 159.Uren E, Elsum R, Jack I. A comparative study of the diagnosis of respiratory virus infections by immunofluorescence and virus isolation in children. Aust Paediatr J. 1977;13:282–286. doi: 10.1111/j.1440-1754.1977.tb01163.x. [DOI] [PubMed] [Google Scholar]
  • 160.Hughes JH. Physical and chemical methods for enhancing rapid detection of viruses and other agents. Clin Microbiol Rev. 1993;6:150–175. doi: 10.1128/cmr.6.2.150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 161.Bressoud A, Whitcomb J, Pourzand Rapid detection of influenza virus H1 by the polymerase chain reaction. Biochem Biophys Res Commun. 1990;167:425–530. doi: 10.1016/0006-291x(90)92040-7. [DOI] [PubMed] [Google Scholar]
  • 162.Pisareva M, Bechtereva T, Plyusnin A. PCR-amplification of influenza A virus specific sequences. Arch Virol. 1992;125:313–318. doi: 10.1007/BF01309648. [DOI] [PubMed] [Google Scholar]
  • 163.Gilbert LL, Dakhama A, Bone BM. Diagnosis of viral respiratory tract infections in children by using a reverse transcription-PCR panel. J Clin Microbiol. 1996;34:140–143. doi: 10.1128/jcm.34.1.140-143.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 164.Karron RA, Frochlich JL, Bobo L. Rapid detection of parainfluenza virus type 3 RNA in respiratory specimens: Use of reverse transcription-PCR-enzyme immunoassay. J Clin Microbiol. 1994;32:484–488. doi: 10.1128/jcm.32.2.484-488.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 165.Fan J, Henrickson KJ. Rapid diagnosis of human parainfuenza virus type 1 infection by quantitative reverse transcription-PCR-enzyme hybridization assay. J Clin Microbiol. 1996;34:1914–1917. doi: 10.1128/jcm.34.8.1914-1917.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 166.Gottschalk J, Zbinden R, Kaempf L. Discrimination of respiratory syncytial virus subgroups A and B by reverse transcription-PCR. J Clin Microbiol. 1996;34:41–43. doi: 10.1128/jcm.34.1.41-43.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 167.Freymuth F, Eugene G, Vabret A. Detection of respiratory syncytial virus by reverse transcription-PCR and hybridization with DNA enzyme immunoassay. J Clin Microbiol. 1995;33:3352–3355. doi: 10.1128/jcm.33.12.3352-3355.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 168.Van Milaan AJ, Sprenger MJW, Rothbarth PH. Detection of respiratory syncytial virus by RNA-polymerase chain reaction and differentiation of subgroups with oligonucleotide probes. J Med Virol. 1994;44:80–87. doi: 10.1002/jmv.1890440115. [DOI] [PubMed] [Google Scholar]
  • 169.Class ECJ, Sprenger MJW, Kleter GEM. Type-specific identification of influenza viruses A, B, and C by the polymerase chain reaction. J Virol Methods. 1992;39:1–13. doi: 10.1016/0166-0934(92)90120-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 170.Atmar RL, Baxter BD, Dominguez EA. Comparison of reverse transcription-PCR with tissue culture and and other rapid diagnostic assays for detection of type A influenza virus. J Clin Microbiol. 1996;34:2604–2606. doi: 10.1128/jcm.34.10.2604-2606.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 171.Freymuth F, Vabret A, Galateau-Salle F. Detection of respiratory syncytial virus, parainfluenza virus 3, adenovirus and rhinovirus sequences in respiratory tract of infants by polymerase chain reaction and hybridization. Clin Diagn Virol. 1997;8:31–40. doi: 10.1016/s0928-0197(97)00060-3. [DOI] [PubMed] [Google Scholar]
  • 172.Macnaughton MR, Flowers D, Isaacs D. Diagnosis of human coronavirus infections in children using enzyme-linked immunosorbent assay. J Med Virol. 1983;11:319–325. doi: 10.1002/jmv.1890110407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 173.Yeager CL, Ashmun RA, Williams RK. Human aminopeptidase N is a receptor for human coronavirus 229A. Nature. 1992;357:420–422. doi: 10.1038/357420a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 174.MacDonald NE, Hall CB, Suffin SC. Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med. 1982;307:397–400. doi: 10.1056/NEJM198208123070702. [DOI] [PubMed] [Google Scholar]
  • 175.Abman SH, Ogle JW, Butler-Simon N. Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis. J Pediatr. 1988;113:826–830. doi: 10.1016/s0022-3476(88)80008-8. [DOI] [PubMed] [Google Scholar]
  • 176.Groothius JR, Gutirrez KM, Lauer BA. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics. 1988;82:199–203. [PubMed] [Google Scholar]
  • 177.Meert K, Heidemann S, Lich-Lai M. Clinical characteristics of respiratory syncytial virus infections in healthy versus previously compromised host. Pediatr Pulmonol. 1989;7:167–170. doi: 10.1002/ppul.1950070309. [DOI] [PubMed] [Google Scholar]
  • 178.Hall CB, Powell DR, MacDonald NE. Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med. 1986;315:77–80. doi: 10.1056/NEJM198607103150201. [DOI] [PubMed] [Google Scholar]
  • 179.Fishaut M, Tubergen D, McIntosh K. Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity. Pediatr Infect Dis J. 1980;96:179–186. doi: 10.1016/s0022-3476(80)80799-2. [DOI] [PubMed] [Google Scholar]
  • 180.Ogra PL, Patel J. Respiratory syncytial virus infection and the immunocompromised host. Pediatr Infect Dis J. 1988;7:246–249. doi: 10.1097/00006454-198804000-00002. [DOI] [PubMed] [Google Scholar]
  • 181.Heidemann SM. Clinical characteristics of parainfluenza virus infection in hospitalized children. Pediatr Pulmonol. 1992;13:86–89. doi: 10.1002/ppul.1950130205. [DOI] [PubMed] [Google Scholar]
  • 182.Church NR, Anas NG, Hall CB. Respiratory syncytial virus-related apnea in infants. Demographics and outcome. Am J Dis Child. 1984;138:247–250. doi: 10.1001/archpedi.1984.02140410027010. [DOI] [PubMed] [Google Scholar]
  • 183.Anas N, Boettrich C, Hall CB. The association of apnea and respiratory syncytial virus in infants. J Pediatr. 1982;101:65–68. doi: 10.1016/s0022-3476(82)80184-4. [DOI] [PubMed] [Google Scholar]
  • 184.Wright PF, Ross KB, Thompson J. Influenza A infections in young children. N Engl J Med. 1977;296:829–834. doi: 10.1056/NEJM197704142961501. [DOI] [PubMed] [Google Scholar]
  • 185.Korppi M, Leinonen M, Malela PH. Bacterial involvement in parainfluenza virus infection in children. Scand J Infect Dis. 1990;22:307–312. doi: 10.3109/00365549009027052. [DOI] [PubMed] [Google Scholar]
  • 186.Hall CB, Hall WJ, Gala CL. Long-term prospective study in children after respiratory syncytial virus infection. J Pediatr. 1984;105:358–364. doi: 10.1016/s0022-3476(84)80005-0. [DOI] [PubMed] [Google Scholar]
  • 187.Henry PL, Hodges IG, Milner AD. Respiratory problems two years after acute bronchiolitis in infancy. Arch Dis Child. 1983;58:713–716. doi: 10.1136/adc.58.9.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 188.Duiverman EF, Neijens HJ, van Strik P. Lung function and bronchial responsiveness in children who had infantile bronchiolitis. Pediatr Pulmonol. 1987;3:38–44. doi: 10.1002/ppul.1950030111. [DOI] [PubMed] [Google Scholar]
  • 189.O'Reilly JF. Adult bronchiolitis and parainfluenza type 2. Postgrad Med J. 1980;56:787–788. doi: 10.1136/pgmj.56.661.787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 190.Einarsson O, Geba GP, Zhu Z. Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness. J Clin Invest. 1996;97:915–924. doi: 10.1172/JCI118514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 191.Uhl EW, Castleman WL, Sorkness RL. Parainfluenza virus-induced persistence of airway inflammation, fibrosis, and dysfunction associated with TGF-beta 1 expression in brown Norway rats. Am J Respir Crit Care Med. 1996;154:1834–1842. doi: 10.1164/ajrccm.154.6.8970378. [DOI] [PubMed] [Google Scholar]
  • 192.Sorkness R, Lemanske RFJ, Castleman WL. Persistent airway hyperresponsiveness after neonatal viral bronchiolitis in rats. J Appl Physiol. 1991;70:375–383. doi: 10.1152/jappl.1991.70.1.375. [DOI] [PubMed] [Google Scholar]
  • 193.Siber GR, Leszcynski J, Pena-Cruz Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay. J Infect Dis. 1992;165:456–463. doi: 10.1093/infdis/165.3.456. [DOI] [PubMed] [Google Scholar]
  • 194.Hemming VG, Prince GZ, Horswood RL. Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model. J Infect Dis. 1985;152:1083–1087. doi: 10.1093/infdis/152.5.1083. [DOI] [PubMed] [Google Scholar]
  • 195.Piga N, Kessler N, Layani MP. Correlation between the reactivity patterns of monoclonal antibodies to distinct antigenic sites on HN glycoprotein and their protective abilities in Sendai (6/94) virus infection. Arch Virol. 1990;110:179–193. doi: 10.1007/BF01311287. [DOI] [PubMed] [Google Scholar]
  • 196.Groothuis JR, Simoes EAF, Levin MJ. Prophylactic administration of respiratory syncytial virus immune globulin to high risk infants and young children. N Engl J Med. 1993;329:1524–1530. doi: 10.1056/NEJM199311183292102. [DOI] [PubMed] [Google Scholar]
  • 197.Connor E, PREVENT Study Group Reduction of RSV hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. Pediatrics. 1997;99:93–99. doi: 10.1542/peds.99.1.93. [DOI] [PubMed] [Google Scholar]
  • 198.American Academy of Pediatrics Respiratory syncytial virus immune globulin intravenous: Indications for use. Pediatrics. 1997;99:645–650. [PubMed] [Google Scholar]
  • 199.a. Shult PA, Dick EC, Mink KA. American Society for Microbiology; Atlanta, GA: October 1990. Diminished rhinovirus (RV) illness severity correlates with increased leukocyte ascorbic acid (AA) levels; p. 189. (Abstracts of the 1990 ICAAC). No. 617. [Google Scholar]
  • 199.b. Hemila H. Vitamin C intake and susceptibility to pneumonia. Pediatr Infect Dis. 1997;16:836–837. doi: 10.1097/00006454-199709000-00003. [DOI] [PubMed] [Google Scholar]
  • 200.Daulaire NM, Starbuck ES, Houston RM. Childhood mortality after a high dose of vitamin a in high risk population. Br Med J. 1992;304:207–210. doi: 10.1136/bmj.304.6821.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 201.Frieden TR, Sowell AL, Henning KJ. Vitamin A levels and severity of measles. Am J Dis Child. 1992;146:182–186. doi: 10.1001/archpedi.1992.02160140048019. [DOI] [PubMed] [Google Scholar]
  • 202.Hussey GD, Klein M. A randomized, controlled trial of vitamin A in children with severe measles. N Engl J Med. 1990;323:160–164. doi: 10.1056/NEJM199007193230304. [DOI] [PubMed] [Google Scholar]
  • 203.Coutsoudis A, Coovadia HM, Broughton M. Micronutrient utilization during measles treated with vitamin A or placebo. Int J Vitam Nutr Res. 1991;61:199–204. [PubMed] [Google Scholar]
  • 204.Arrieta AC, Zaleska M, Stutman HR. Vitamin A levels in children with measles in Long Beach, California. J Pediatr. 1992;121:75–78. doi: 10.1016/s0022-3476(05)82545-4. [DOI] [PubMed] [Google Scholar]
  • 205.Sijtsma SR, Rombout JH, West CE. Vitamin A deficiency impairs cytotoxic T lymphocyte activity in Newcastle disease virus-infected chickens. Vet Immunol Immunopathol. 1990;26:191–202. doi: 10.1016/0165-2427(90)90067-3. [DOI] [PubMed] [Google Scholar]
  • 206.Lida J, Saiki I, Ishihara C. Prophylactic activity against Sendai virus infection and macrophage activation with lipophilic derivatives of N-acetylglucosaminylmuramyl tri- or tetrapeptides. Vaccine. 1989;7:225–228. doi: 10.1016/0264-410x(89)90233-8. [DOI] [PubMed] [Google Scholar]
  • 207.Lida J, Ishihara C, Mizukoshi M. Prophylactic activity of dihydronepatrenoi, a synthetic polyprenol derivative, against Sendai virus infection in mice. Vaccine. 1990;83:376–380. doi: 10.1016/0264-410x(90)90097-6. [DOI] [PubMed] [Google Scholar]
  • 208.Hill DA, Baron S, Chanock RM. Sensitivity of common respiratory viruses to an interferon inducer in human cells. Lancet. 1969;2:187–188. doi: 10.1016/s0140-6736(69)91425-1. [DOI] [PubMed] [Google Scholar]
  • 209.Prince GA, Hemming VG, Chanock RM. The use of purified immunoglobulin in the therapy of respiratory syncytial virus infection. Pediatr Infect Dis. 1997;5:S201–S203. [PubMed] [Google Scholar]
  • 210.Hemming VG, Rodriguez W, Kim HW. Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children. Antimicrob Agents Chemother. 1987;31:1882–1886. doi: 10.1128/aac.31.12.1882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 211.Piazza FM, Johnson SA, Ottolini MG. Immunotherapy of respiratory syncytial virus infection in cotton rats (Sigmodon fulviventer) using IgG in a small-particle aerosol. J Infect Dis. 1992;166:1422–1424. doi: 10.1093/infdis/166.6.1422. [DOI] [PubMed] [Google Scholar]
  • 212.Dagan R, Schwartz RH, Insel RA. Severe diffuse adenovirus 7a pneumonia in a child with combined immunodeficiency possible therapeutic effect of human immune serum globulin containing specific neutralizing antibody. Pediatr Infect Dis J. 1984;3:246–250. doi: 10.1097/00006454-198405000-00015. [DOI] [PubMed] [Google Scholar]
  • 213.Lau YL, Levinsky RJ, Morgan G. Dual meningoencephalitis with echovirus type 11 and adenovirus in combined (common variable) immunodeficiency. Pediatr Infect Dis J. 1988;7:873–876. [PubMed] [Google Scholar]
  • 214.Wong JP, Stadnyk LL. American Society for Microbiology; Anaheim, CA: October 11–14, 1992. Prophylaxis and treatment of influenza A virus infection by liposome-mediated passive immunity; p. 370. (Abstracts of the 1992 ICAAG). No. 1557. [Google Scholar]
  • 215.Rodriguez WJ, Gruber WC, Welliver RC. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections. Pediatrics. 1997;99:454–461. doi: 10.1542/peds.99.3.454. [DOI] [PubMed] [Google Scholar]
  • 216.Ingimarsson S, Cantell K, Strander H. Side effects of long-term treatment with human leukocyte interferon. J Infect Dis. 1979;140:560–563. doi: 10.1093/infdis/140.4.560. [DOI] [PubMed] [Google Scholar]
  • 217.Kitajewski J, Schneider RJ, Safer B. Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced elf-2alpha kinase. Cell. 1986;45:195–200. doi: 10.1016/0092-8674(86)90383-1. [DOI] [PubMed] [Google Scholar]
  • 218.Knight V, McClung HW, Wilson SZ. Ribarivin small-particle aerosol treatment of influenza. Lancet. 1981;2:945–949. doi: 10.1016/s0140-6736(81)91152-1. [DOI] [PubMed] [Google Scholar]
  • 219.Knight V, Gilbert BE. Ribarivin acrosol treatment of influenza. Antiviral Chemother. 1987;1:441–457. [PubMed] [Google Scholar]
  • 220.Gilbert BE, Wilson SZ, Knight V. Ribavirin small-particle aerosol treatment of infections caused by influenza virus strains A/Victoria/7/83 (HIN1) and B/Texas/84. Antimicrob Agents Chemother. 1985;27:309–313. doi: 10.1128/aac.27.3.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 221.Knight V, Gilbert B. Antiviral therapy with small particle aerosols. Eur J Clin Microbiol Infect Dis. 1988;7:721–731. doi: 10.1007/BF01975037. [DOI] [PubMed] [Google Scholar]
  • 222.Hall CB, McBride JT, Walsh EE. Aerosolized ribaviron treatment of infants with respiratory syncytial viral infection. N Engl J Med. 1983;308:1443–1447. doi: 10.1056/NEJM198306163082403. [DOI] [PubMed] [Google Scholar]
  • 223.Hall CB, McBride JT, Gala CL. Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease. JAMA. 1985;254:3047–3051. [PubMed] [Google Scholar]
  • 224.Rodriguez WJ, Kim HW, Brandt CD. Aerosolized ribarivin in the treatment of patients with respiratory syncytial virus disease. Pediatr Infect Dis J. 1987;6:159–163. doi: 10.1097/00006454-198702000-00004. [DOI] [PubMed] [Google Scholar]
  • 225.Peter G, editor. Report of the Committee on Infectious Diseases. American Academy of Pediatrics; Elk Grove Village, IL: 1997. [Google Scholar]
  • 226.Englund JA, Piedra PA, Kim YM. American Society for Microbiology; Anaheim, CA: October 11–14, 1992. High dose-short duration aerosolized ribavirin (Hi) vs. Conventional (Reg) ribavirin (rib) therapy for the treatment of respiratory syncytial virus (RSV) infection in children; p. 179. (Abstracts of the 1992 ICAAC). No. 412. [Google Scholar]
  • 227.Sparrelid E, Ljungman P, Ekelof-Andstrom E. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections. Bone Marrow Transplant. 1987;19:905–908. doi: 10.1038/sj.bmt.1700752. [DOI] [PubMed] [Google Scholar]
  • 228.Sidwell RW. Ribavirus. In vitro antiviral activity. In: Smith RA, Kirkpatrick W, editors. Ribavirin: A Broad Spectrum Antiviral Agent. Academic; New York, NY: 1980. pp. 43–58. [Google Scholar]
  • 229.Wreghitt TG, Gray JJ, Ward KN. Disseminated adenovirus infection after liver transplantation and its possible treatment and gancyclovir (letter) J Infect. 1989;19:88–89. doi: 10.1016/s0163-4453(89)95214-6. [DOI] [PubMed] [Google Scholar]
  • 230.Couch RB. Respiratory diseases. In: Galasso GJ, Whitley RJ, Merigan TC, editors. Antiviral Agents and Viral Diseases of Man. Raven; New York, NY: 1990. pp. 327–372. [Google Scholar]
  • 231.Barnett J, Dempsey M, Tisdale M. Susceptibility monitoring of influenza virus clinical isolates to the neuraminidase inhibitor zanamivir (GG167) during phase II clinical efficacy trials. Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy; Toronto, Canada, Am Soc Microbiol; 1997. (abstr 1193) [Google Scholar]
  • 232.Newman SP, Brown J, Pickford M. Deposition pattern in the respiratory tract of the neuraminidase inhibitor zanamivir, a gamma scintigraphic study. Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy; Toronto, Canada, Am Soc. Microbiol; September 28–October 1, 1997. (abstr H134) [Google Scholar]
  • 233.Saez-Llorens X, Castano E, Sanchez P. Phase I/II, open-label, multi-dose escalation trial of a humanized respiratory virus (RSV) monoclonal antibody (Medi-493) administered intramuscularly (IM) in high risk children. Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy; Toronto, Canada, Am Soc Microbiol; September 28–October 1, 1997. (abstr H89) [Google Scholar]
  • 234.Schwartz AR, Togo Y, Hornick RB. Clinical evaluation of live, oral types 1, 2, and 5 adenovirus vaccines. Am Rev Respir Dis. 1974;109:233–239. doi: 10.1164/arrd.1974.109.2.233. [DOI] [PubMed] [Google Scholar]
  • 235.Gruber WC, Belshe RB, King JC. Evaluation of live attenuated influenza vaccines in children 6–18 months of age: Immunogenicity, and efficacy. J Infect Dis. 1996;173:1313–1319. doi: 10.1093/infdis/173.6.1313. [DOI] [PubMed] [Google Scholar]
  • 236.Crowe JE. Current approaches to the development of vaccines against disease caused by respiratory syncytial virus (RSV) and parainfluenza virus (PIV) Vaccine. 1995;13:415–421. doi: 10.1016/0264-410x(95)98266-d. [DOI] [PubMed] [Google Scholar]
  • 237.Collins PL, Davis A, Lubeck M. Modern Approaches to New Vaccines Including Prevention of AIDS. Cold Spring Harbor Laboratory; Cold Spring Harbor, NY: 1989. Evaluation of the protective efficacy of recombinant vaccinia viruses and adenoviruses that express respiratory syncytial virus glycoproteins; p. 26. [Google Scholar]
  • 238.Olmstead RA, Buller RM, Collins PL. Evaluation in nonhuman primates of the safety, immunogenicity and efficacy of recombinant vaccinia viruses expressing the F or G glycoprotein or respiratory syncytial virus. Vaccine. 1989;6:519–524. doi: 10.1016/0264-410x(88)90104-1. [DOI] [PubMed] [Google Scholar]
  • 239.Collins PL, Purcell RH, London LA. Evaluation in chimpanzees of vaccinia virus recombinants that express the surface glycoproteins of human respiratory syncytial virus. Vaccine. 1990;8:164–168. doi: 10.1016/0264-410x(90)90141-8. [DOI] [PubMed] [Google Scholar]
  • 240.Tristram DA, Welliver RC. American Society of Microbiology; Anaheim, CA: October 11–14, 1992. Comparative immunogenicity and safety of 2 respiratory syncytial virus (RSV) fusion (F) protein vaccines in 12–30 m children; p. 125. (Abstracts of the 1992 ICAAC). No. 86. [Google Scholar]
  • 241.Wathan MW, Kakuk TJ, Brideau RJ. vaccination of cotton rats with a chimeric FG glycoprotein of human respiratory syncytial virus induces minimal pulmonary pathology on challenge. J Infect Dis. 1991;163:477–482. doi: 10.1093/infdis/163.3.477. [DOI] [PubMed] [Google Scholar]
  • 242.Olmsted RA, Elango N, Prince GA. Vol. 83. 1986. Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: Comparison of the individual contributions of the F and G glycoprotein to host immunity; pp. 7462–7466. (Proc Natl Sci Acad USA). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 243.Du RP, Jackson GED, Wyde PR. A prototype recombinant vaccine against respiratory syncytial virus and parainfluenza virus type 3 (letter) Biotechnology. 1994;12:813. doi: 10.1038/nbt0894-813. [DOI] [PubMed] [Google Scholar]
  • 244.Murphy BR, Hall SL, Kulkami AB. An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines. Virus Res. 1994;32:13–36. doi: 10.1016/0168-1702(94)90059-0. [DOI] [PubMed] [Google Scholar]
  • 245.Crowe JE, Bui PT, Firestone CY. Live subgroup B respiratory syncytial virus vaccines that are attenuated, genetically stable, and immunogenic in rodents and nonhuman primates. J Infect Dis. 1996;173:829–839. doi: 10.1093/infdis/173.4.829. [DOI] [PubMed] [Google Scholar]
  • 246.Firestone GY, Whitchead SS, Collins PL. Nucleotide sequence analysis of the respiratory syncytial virus subgroup A cold passaged (cp) temperature sensitive (ts) cpts-248/404 live attenuated virus vaccine candidate. Virology. 1996;225:419–422. doi: 10.1006/viro.1996.0618. [DOI] [PubMed] [Google Scholar]
  • 247.Belshe RB, Karron RA, Newman FK. Evaluation of a live attenuated, cold-adapted parainfluenza virus type 3 in children. J Clin Micro. 1992;30:2064–2070. doi: 10.1128/jcm.30.8.2064-2070.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 248.Ray R, Galinski MS, Heminway BR. Temperature-sensitive phenotype of the human parainfluenza virus type 3 candidate vaccine strain (cp45) correlates with a defect in the L gene. J Virol. 1996;70:580–584. doi: 10.1128/jvi.70.1.580-584.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 249.Clements ML, Belshe RB, King J. Evaluation of bovine, cold-adapted human and wild-type human parainfluenza type 3 viruses in adult volunteers and in chimpanzees. J Clin Microbiol. 1991;29:1175–1182. doi: 10.1128/jcm.29.6.1175-1182.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 250.Karron RA, Wright PF, Hall SL. A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children. J Infect Dis. 1995;171:1107–1114. doi: 10.1093/infdis/171.5.1107. [DOI] [PubMed] [Google Scholar]
  • 251.Spriggs MK, Murphy BR, Prince GA. Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity. J Virol. 1987;61:3416–3423. doi: 10.1128/jvi.61.11.3416-3423.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 252.Spriggs MK, Collins PL, Tierney E. Immunization with vaccinia virus recombinants that express the surface glycoproteins of human parainfluenza virus type 3 (PIV3) protects patas monkeys against PIV3 infection. J Virol. 1988;62:1293–1296. doi: 10.1128/jvi.62.4.1293-1296.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 253.van Wyke Coelingh KL, Winter CC, Jorgensen ED. Antigenic and structural properties of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3: Sequence analysis of variants selected with monoclonal antibodies which inhibit infectivity, hemagglutination, and neuraminidase activities. J Virol. 1987;61:1473–1477. doi: 10.1128/jvi.61.5.1473-1477.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 254.Ambrose MW, Wyde PR, Ewasyshyn M. Evaluation of the immunogenicity and protective efficacy of a candidate parainfluenza virus type 3 subunit vaccine in cotton rats. Vaccine. 1991;9:505–511. doi: 10.1016/0264-410x(91)90037-7. [DOI] [PubMed] [Google Scholar]
  • 255.Spriggs MK, Collins PL, Tierney E. Immunization with vaccinia virus recombinants that express the surface glycoproteins of human parainfluenza virus type 3 (PIV3) protects patas monkeys against PIV3 infection. J Virol. 1988;62:1293–1296. doi: 10.1128/jvi.62.4.1293-1296.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 256.Ewasyshyn M, Caplan B, Bonneau AM. Comparative analysis of the immunostimulatory properties of different adjuvants on the immunogenicity of a prototype parainfluenza virus type 3 subunit vaccine. Vaccine. 1992;10:412–420. doi: 10.1016/0264-410x(92)90072-r. [DOI] [PubMed] [Google Scholar]
  • 257.Tumova B, Heinz F, Syrucek L. Occurrence and aetiology of acute respiratory diseases: Results of a long term surveillance programme. Acta Virol. 1988;33:50–62. [PubMed] [Google Scholar]
  • 258.Hietala J, Rhari M, Tukko H. Antigen detection in the diagnosis of viral infections. Scand J Infect Dis. 1988;77:595–599. doi: 10.3109/00365548809035659. [DOI] [PubMed] [Google Scholar]
  • 259.Kellner G, Popow-Kraupp T, Kundi M. Clinical manifestations of respiratory tract infections due to respiratory syncytial virus and rhinoviruses in hospitalized children. Acta Paediatr Scan. 1989;78:390–394. doi: 10.1111/j.1651-2227.1989.tb11098.x. [DOI] [PubMed] [Google Scholar]

Articles from Seminars in Pediatric Infectious Diseases are provided here courtesy of Elsevier

RESOURCES